Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004495 · ClinicalTrials.gov registry record · NA
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT00004495 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 84 participants.
The verdict
NCT00004495, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Compare the efficacy of two doses of folic acid in normalizing plasma total homocysteine concentration in patients with end stage renal disease receiving regular hemodialysis therapy resulting in hyperhomocysteinemia. II. Determine the requirement of co-supplementation with extra pyridoxine (vitamin B6) and cyanocobalamin (vitamin B12) daily in these patients. III. Assess the safety and tolerability of this therapy in these patients.
Interventions
- DRUG pyridoxine
- DRUG cyanocobalamin
- DRUG folic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 1999-06 |
| Est. Completion | 2000-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004495
The ClinicalTrials.gov registry entry for NCT00004495 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which pyridoxine is the first listed.
NCT00004495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004495 about?
NCT00004495 is a clinical study titled "Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis". OBJECTIVES: I. Compare the efficacy of two doses of folic acid in normalizing plasma total homocysteine concentration in patients with end stage renal disease receiving regular hemodialysis therapy resulting in hyperhomocysteinemia. II. Determine the requirement of co-supplementation with extra pyr...
What is the current status of trial NCT00004495?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 1999-06. Estimated completion is 2000-09.
What interventions are being tested in trial NCT00004495?
The interventions under investigation include: pyridoxine (DRUG), cyanocobalamin (DRUG), folic acid (DRUG).
Who is sponsoring clinical trial NCT00004495?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.